Among these genes, Previous studies found that abnormal expression of ARNTL was associated with tumor proliferation, cell cycle, survival outcomes as well as chemotherapy sensitivity in various cancers [16, 21–24], suggesting that ARNTL could act as a potential therapeutic target. The gene discussed is BMAL1; the disease is neoplasm.